When Madi Vanstone was 11, she found a medication that would be life changing for her battle against cystic fibrosis, but it came with a catch.

A real-world study in children with cystic fibrosis in the Netherlands found significant improvements in small airway ...

Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome ...

Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome (communities of bacteria) of infants with cystic fibrosis (CF) compared to that ...

Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome ...

In Montreal from Saint John, New Brunswick, on Monday, the Ward family did a bit of sightseeing before arriving at Bell ...

Findings from a new Dartmouth-led study, published in the journal mBio, highlight key differences in the gut microbiome of infants with cystic fibrosis (CF) compared to that of healthy infants, and ...

The effect of cystic fibrosis on many organs and the frequent lung infections means that it is mostly diagnosed in childhood. Somehow, for Verônica Stasiak Bednarczuk, that diagnosis did not arrive ...

Its architect's daughter has cystic fibrosis—and benefits from a "miracle drug" backed by an agency he's attacking.

Note: The verification e-mail to complete your account registration should arrive immediately. However, in some cases it takes longer. Don't forget to check your spam folder.

Drugmakers — major beneficiaries of NIH-backed university research — have been largely silence on the Trump administration's ...

Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex works to build markets for new drugs like Casgevy and Journavx.